Pancreatic Islet Cell Transplant for Treatment of Diabetes

Paolo Fiorina, Antonio Secchi

Research output: Contribution to journalArticle

Abstract

Islet cell transplantation recently has emerged as one the most promising therapeutic approaches to improving glycometabolic control in type 1 diabetic patients, and, in many cases, to obtaining insulin independence. Islet cell transplantation requires a relatively short hospital stay and has the advantage of being a relatively noninvasive procedure. The rate of insulin independence 1 year after islet cell transplantation has improved significantly in recent years (60% at 1 year after transplantation compared to the 15% in the past years). Data from a recent international trial confirmed that islet cell transplantation potentially can be a cure for type 1 diabetes. Recent data indicate that insulin independence after islet cell transplantation is associated with an improvement in glucose metabolism and quality of life and with a reduction in hypoglycemic episodes. Islet cell transplantation is still in its initial stages, and many obstacles still need to be overcome. Once clinical islet transplantation has been established, this treatment could be offered to diabetic patients long before the onset of diabetic complications or to patients with life-threatening hypoglycemic unawareness and brittle diabetes.

Original languageEnglish
Pages (from-to)999-1013
Number of pages15
JournalEndocrinology and Metabolism Clinics of North America
Volume36
Issue number4
DOIs
Publication statusPublished - Dec 2007

Fingerprint

Islets of Langerhans Transplantation
Transplants
Medical problems
Islets of Langerhans
Cell Transplantation
Insulin
Hypoglycemic Agents
Transplantation (surgical)
Metabolism
Therapeutics
Glucose
Diabetes Complications
Type 1 Diabetes Mellitus
Length of Stay
Transplantation
Quality of Life

ASJC Scopus subject areas

  • Endocrinology
  • Biochemistry

Cite this

Pancreatic Islet Cell Transplant for Treatment of Diabetes. / Fiorina, Paolo; Secchi, Antonio.

In: Endocrinology and Metabolism Clinics of North America, Vol. 36, No. 4, 12.2007, p. 999-1013.

Research output: Contribution to journalArticle

@article{e0e2cac77dc44ae1bd7603db42060f32,
title = "Pancreatic Islet Cell Transplant for Treatment of Diabetes",
abstract = "Islet cell transplantation recently has emerged as one the most promising therapeutic approaches to improving glycometabolic control in type 1 diabetic patients, and, in many cases, to obtaining insulin independence. Islet cell transplantation requires a relatively short hospital stay and has the advantage of being a relatively noninvasive procedure. The rate of insulin independence 1 year after islet cell transplantation has improved significantly in recent years (60{\%} at 1 year after transplantation compared to the 15{\%} in the past years). Data from a recent international trial confirmed that islet cell transplantation potentially can be a cure for type 1 diabetes. Recent data indicate that insulin independence after islet cell transplantation is associated with an improvement in glucose metabolism and quality of life and with a reduction in hypoglycemic episodes. Islet cell transplantation is still in its initial stages, and many obstacles still need to be overcome. Once clinical islet transplantation has been established, this treatment could be offered to diabetic patients long before the onset of diabetic complications or to patients with life-threatening hypoglycemic unawareness and brittle diabetes.",
author = "Paolo Fiorina and Antonio Secchi",
year = "2007",
month = "12",
doi = "10.1016/j.ecl.2007.07.004",
language = "English",
volume = "36",
pages = "999--1013",
journal = "Endocrinology and Metabolism Clinics of North America",
issn = "0889-8529",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Pancreatic Islet Cell Transplant for Treatment of Diabetes

AU - Fiorina, Paolo

AU - Secchi, Antonio

PY - 2007/12

Y1 - 2007/12

N2 - Islet cell transplantation recently has emerged as one the most promising therapeutic approaches to improving glycometabolic control in type 1 diabetic patients, and, in many cases, to obtaining insulin independence. Islet cell transplantation requires a relatively short hospital stay and has the advantage of being a relatively noninvasive procedure. The rate of insulin independence 1 year after islet cell transplantation has improved significantly in recent years (60% at 1 year after transplantation compared to the 15% in the past years). Data from a recent international trial confirmed that islet cell transplantation potentially can be a cure for type 1 diabetes. Recent data indicate that insulin independence after islet cell transplantation is associated with an improvement in glucose metabolism and quality of life and with a reduction in hypoglycemic episodes. Islet cell transplantation is still in its initial stages, and many obstacles still need to be overcome. Once clinical islet transplantation has been established, this treatment could be offered to diabetic patients long before the onset of diabetic complications or to patients with life-threatening hypoglycemic unawareness and brittle diabetes.

AB - Islet cell transplantation recently has emerged as one the most promising therapeutic approaches to improving glycometabolic control in type 1 diabetic patients, and, in many cases, to obtaining insulin independence. Islet cell transplantation requires a relatively short hospital stay and has the advantage of being a relatively noninvasive procedure. The rate of insulin independence 1 year after islet cell transplantation has improved significantly in recent years (60% at 1 year after transplantation compared to the 15% in the past years). Data from a recent international trial confirmed that islet cell transplantation potentially can be a cure for type 1 diabetes. Recent data indicate that insulin independence after islet cell transplantation is associated with an improvement in glucose metabolism and quality of life and with a reduction in hypoglycemic episodes. Islet cell transplantation is still in its initial stages, and many obstacles still need to be overcome. Once clinical islet transplantation has been established, this treatment could be offered to diabetic patients long before the onset of diabetic complications or to patients with life-threatening hypoglycemic unawareness and brittle diabetes.

UR - http://www.scopus.com/inward/record.url?scp=35648982927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35648982927&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2007.07.004

DO - 10.1016/j.ecl.2007.07.004

M3 - Article

C2 - 17983933

AN - SCOPUS:35648982927

VL - 36

SP - 999

EP - 1013

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

IS - 4

ER -